These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37762551)

  • 1. Lipid-Based Nanocarriers for Delivery of Neuroprotective Kynurenic Acid: Preparation, Characterization, and BBB Transport.
    Juhász Á; Ungor D; Varga N; Katona G; Balogh GT; Csapó E
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased blood-brain barrier permeability of neuroprotective drug by colloidal serum albumin carriers.
    Hornok V; Amin KWK; Kovács AN; Juhász Á; Katona G; Balogh GT; Csapó E
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112935. PubMed ID: 36265318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of the kynurenic acid across the blood-brain barrier by core-shell nanoparticles.
    Varga N; Csapó E; Majláth Z; Ilisz I; Krizbai IA; Wilhelm I; Knapp L; Toldi J; Vécsei L; Dékány I
    Eur J Pharm Sci; 2016 Apr; 86():67-74. PubMed ID: 26924227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pH-Dependent Controlled Release of Encapsulated Vitamin B
    Juhász Á; Ungor D; Várkonyi EZ; Varga N; Csapó E
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenic Acid and Its Synthetic Derivatives Protect Against Sepsis-Associated Neutrophil Activation and Brain Mitochondrial Dysfunction in Rats.
    Poles MZ; Nászai A; Gulácsi L; Czakó BL; Gál KG; Glenz RJ; Dookhun D; Rutai A; Tallósy SP; Szabó A; Lőrinczi B; Szatmári I; Fülöp F; Vécsei L; Boros M; Juhász L; Kaszaki J
    Front Immunol; 2021; 12():717157. PubMed ID: 34475875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and properties of nanoscale containers for biomedical application in drug delivery: preliminary studies with kynurenic acid.
    Hornok V; Bujdosó T; Toldi J; Nagy K; Demeter I; Fazakas C; Krizbai I; Vécsei L; Dékány I
    J Neural Transm (Vienna); 2012 Feb; 119(2):115-21. PubMed ID: 22065206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation.
    Ding H; Sagar V; Agudelo M; Pilakka-Kanthikeel S; Atluri VS; Raymond A; Samikkannu T; Nair MP
    Nanotechnology; 2014 Feb; 25(5):055101. PubMed ID: 24406534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment.
    Gabay M; Weizman A; Zeineh N; Kahana M; Obeid F; Allon N; Gavish M
    Cell Mol Neurobiol; 2021 Jul; 41(5):1019-1029. PubMed ID: 33025416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenic acid and its derivatives are able to modulate the adhesion and locomotion of brain endothelial cells.
    Lajkó E; Tuka B; Fülöp F; Krizbai I; Toldi J; Magyar K; Vécsei L; Kőhidai L
    J Neural Transm (Vienna); 2018 Jun; 125(6):899-912. PubMed ID: 29332257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
    Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
    Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain.
    Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
    J Pharmacol Exp Ther; 2020 Sep; 374(3):354-365. PubMed ID: 32561686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability.
    Oláh G; Herédi J; Menyhárt A; Czinege Z; Nagy D; Fuzik J; Kocsis K; Knapp L; Krucsó E; Gellért L; Kis Z; Farkas T; Fülöp F; Párdutz A; Tajti J; Vécsei L; Toldi J
    Drug Des Devel Ther; 2013; 7():981-7. PubMed ID: 24068867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constant pressure-controlled extrusion method for the preparation of Nano-sized lipid vesicles.
    Morton LA; Saludes JP; Yin H
    J Vis Exp; 2012 Jun; (64):. PubMed ID: 22760481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
    Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
    Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
    Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
    Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential.
    Juhairiyah F; de Lange ECM
    AAPS J; 2021 Oct; 23(6):114. PubMed ID: 34713363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Approaches and Success of Liposome-Based Nano Drug Carriers for the Treatment of Brain Tumor.
    Shaw TK; Paul P
    Curr Drug Deliv; 2022; 19(8):815-829. PubMed ID: 34961462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.
    Calvagno MG; Celia C; Paolino D; Cosco D; Iannone M; Castelli F; Doldo P; Frest M
    Curr Drug Deliv; 2007 Jan; 4(1):89-101. PubMed ID: 17269921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid.
    Füvesi J; Somlai C; Németh H; Varga H; Kis Z; Farkas T; Károly N; Dobszay M; Penke Z; Penke B; Vécsei L; Toldi J
    Pharmacol Biochem Behav; 2004 Jan; 77(1):95-102. PubMed ID: 14724046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.